Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Azoximer bromide, marketed as Polyoxidonium, is a high-molecular-weight synthetic cationic polymer used primarily as an immunomodulator and adjuvant. It is designed to enhance the body's immune response against infections and has additional detoxifying and antioxidant properties. It acts broadly on both innate and adaptive immunity by enhancing cellular responses while also providing antioxidant/detoxicating benefits. Its use spans infection prevention/treatment through support during cancer therapies but requires more robust clinical validation per international standards before widespread adoption outside its current markets.
Stimulates innate and adaptive immunity, activates NF-kB pathway, and modulates hydrogen peroxide concentrations within cells leading to antioxidant and detoxifying effects.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Azoximer Bromide.